Dallas Matthew D
Chief Financial Officer at CoLucid Pharmaceuticals, Inc.; VP, Finance at AVEO PHARMACEUTICALS INC
- Sold, on record
- $108k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jan 3, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CoLucid Pharmaceuticals, Inc.Chief Financial Officer
- AVEO PHARMACEUTICALS INCVP, Finance
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- AVEO PHARMACEUTICALS INC3,594 shares
- CoLucid Pharmaceuticals, Inc.2,946 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AVEO PHARMACEUTICALS INCPlan not statedJan 7, 2015 2015
Sold 519 shares at $0.80 ($415)
Dallas Matthew D, VP, Finance
Sold 2.9% of holdings ($14k position)17,581 shares leftFirst sale on recordFiling
- 2 Form 4 sale AVEO PHARMACEUTICALS INCPlan not statedJan 16, 2015 +9 days
Sold 3,075 shares at $0.82 ($3k)
Dallas Matthew D, VP, Finance
Sold 17.5% of holdings ($14k position)14,506 shares leftFiling
- 3 Form 4 sale CoLucid Pharmaceuticals, Inc.Plan not statedDec 1, 2016 +685 days
Sold 1,473 shares at $35.17 ($52k)
Dallas Matthew D, Chief Financial Officer
Sold 3.4% of holdings ($1.5M position)41,601 shares leftFirst sale on recordFiling
- 4 Form 4 sale CoLucid Pharmaceuticals, Inc.Plan not statedJan 3, 2017 +33 days
Sold 1,473 shares at $36.25 ($53k)
Dallas Matthew D, Chief Financial Officer
Sold 3.5% of holdings ($1.5M position)40,128 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2017 | Jan 4, 2017 | CoLucid Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,473 | $53k | 3.5% | Plan not stated | SEC |
| Dec 1, 2016 | Dec 1, 2016 | CoLucid Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,473 | $52k | 3.4% | Plan not stated | SEC |
| Jan 16, 2015 | Jan 20, 2015 | AVEO PHARMACEUTICALS INC | VP, Finance | Form 4 sale | 3,075 | $3k | 17.5% | Plan not stated | SEC |
| Jan 7, 2015 | Jan 8, 2015 | AVEO PHARMACEUTICALS INC | VP, Finance | Form 4 sale | 519 | $415 | 2.9% | Plan not stated | SEC |